Canada’s Upstream Cannabis Glut Deepens as Destroyed Flower Hits 18.1% of Output

Q1 2026 destruction jumps to 18.1% even as stores keep selling about C$482 million a month

Canada’s legal cannabis market is still selling a lot of product. It is also still throwing a striking amount of flower away.

Health Canada’s market data show that licensees destroyed unpackaged dried cannabis equal to 18.1% of production in the first quarter of 2026. That was up sharply from 10.7% in the fourth quarter of 2025 and is the highest share in the current public series. In plain terms, nearly a fifth of bulk dried flower produced during the quarter was later destroyed instead of sold.

That number matters because it arrives at a moment when consumer demand has not disappeared. Statistics Canada’s monthly retail data put cannabis store sales at about C$482.6 million in April 2026 and seasonally adjusted cannabis retailer sales at about C$482.5 million in May. The legal market is still moving product at scale. The problem is that a large part of the supply chain is still producing more dried flower than the market can profitably take.

This is why the destruction figure is more than a grim inventory footnote. It is a current signal that Canada’s upstream oversupply problem, especially in commodity flower, has not cleared. For cultivators and processors, it points to more write-downs and weak prices for bulk biomass. For lenders and other creditors, it is a reminder that inventory and cultivation assets can lose value quickly when the market mix shifts. For buyers, it confirms that supply remains loose.

The figure also cuts against the simple idea that time alone would solve Canada’s cannabis imbalance. The legal market is now several years into national adult-use sales. If excess production were merely an early-stage startup problem, destruction at this scale should be fading. Instead, it has surged again.

The wasted flower sits upstream, where bulk cannabis can miss the market before a shopper ever sees it

The phrase Health Canada uses here is important. “Unpackaged dried cannabis” means dried flower that exists in bulk form before final packaging for sale. It is upstream product. A consumer does not see it on a store shelf, and a retailer cannot discount it directly in the way a shop clears old inventory. If that bulk flower cannot be sold into a finished product in time, it may end up being destroyed.

That distinction helps explain why destruction can rise even while store sales stay large. Retail demand measures what shoppers are buying at the end of the chain. The destruction ratio measures what licensed businesses are losing earlier in the chain. Those are connected, but they are not the same thing.

Health Canada’s reporting framework also matters. Licensed businesses in Canada must track production, inventory and destruction under the federal cannabis regime. In practical terms, that means the destruction number is not a rumor about isolated crop failures. It is a regulated data point from the legal supply system. The figures do not identify individual firms or give a case-by-case reason for destruction, but they do show the scale of material that is being written off.

Some destruction is normal in any regulated crop market. Product can fail quality checks, degrade in storage, or become commercially unusable because it is too old, too dry, too inconsistent or simply not worth processing further. Cannabis is especially exposed to that problem because its market value is not just about quantity. Freshness, aroma, potency, appearance and suitability for a specific format all matter. Bulk flower that looked saleable when harvested can lose appeal or economic value months later.

The larger point is structural. Canada built a cultivation base sized for growth that did not arrive evenly across product categories. Dry flower was the original centre of gravity for legal cannabis, and cultivation capacity expanded accordingly. But demand has not held still. Consumers have spread spending across pre-rolls, vapes, other inhaled extracts, edibles and a broader mix of formats. Even where dried flower still matters, buyers often want specific quality tiers, specific genetics and specific package formats. Excess flower in the wrong quality band or strain profile does not become desirable merely because national sales remain high.

The same Health Canada market page that contains the destruction series also continues to show a heavy stock position in dried cannabis relative to sales. That matters because destruction is often the final act in an inventory problem, not the first one. When packaged or bulk stock sits too long, the odds rise that some of it will not clear the market at an acceptable price, or at all.

That is the central reading of the first-quarter spike. Canada does not appear to be short of cannabis demand. It appears to be long the wrong kind of supply, in the wrong quantities, at the wrong point in the chain.

Rising extracts sales and tough wholesale buying keep pressure on cultivators, processors and lenders

The most immediate effect falls on cultivators and processors with heavy exposure to undifferentiated flower. If nearly a fifth of current bulk dried production is being destroyed, the market is still forcing producers to absorb losses rather than recover them through sales. That can show up as lower realized prices, higher inventory provisions, impairment charges on biological assets and a harder case for keeping marginal grow rooms open.

For processors, the message is only slightly better. In theory, excess flower can be diverted into extracts, pre-rolls or value offerings. In practice, that outlet has limits. Input quality still matters. Extraction demand does not absorb every gram. And if too many firms pursue the same fallback strategy, prices for biomass and toll-processing work remain under pressure. A processor with brand strength and disciplined purchasing may benefit from cheap inputs, but a processor that depends on carrying large amounts of bulk stock faces the same ageing and margin risks as a grower.

Retailers and provincial buyers sit on the other side of the equation. Their incentive is not to rescue upstream production. It is to keep shelves productive and inventory turning. In a mature legal market, buyers can be selective. That tends to favour suppliers that offer reliable quality, differentiated genetics, strong pre-roll execution or products already aligned with consumer habits. It punishes growers that still rely on scale alone.

The category mix helps explain why this pressure can persist even while legal spending rises. Statistics Canada said recreational cannabis sales reached C$5.522 billion in the 2024-2025 fiscal year, up 6.1% from the prior year. That is growth, not retrenchment. But the composition of that spending has evolved. Statistics Canada’s release for the same period said inhaled extracts reached 31.1% of total sales. That shift does not make flower irrelevant. It does mean that the market basket is wider, and a business built mainly around bulk dried flower is competing for a smaller share of total consumer attention than before.

There is also a financing angle. Inventory is often treated as a productive asset on the way to sale. Destruction turns that assumption inside out. For lenders, landlords and trade creditors, a high destruction ratio is evidence that not all cannabis inventory deserves to be valued as if it will become cash. That can translate into stricter borrowing terms, more conservative collateral treatment and a lower tolerance for operators that promise volume growth without clear sell-through.

Public companies and their shareholders will read the same signal in a different language. A rising destruction share suggests that some reported production is not economically productive. It may still count as output in a period, but it does not generate revenue if it is later destroyed. That makes headline production figures less impressive than they look and puts more weight on net revenue per gram, inventory ageing, gross margin quality and cash generation.

Medical businesses are not insulated either. Canada’s medical channel is distinct, but the broader wholesale environment still shapes benchmark pricing and cultivation economics. If upstream flower remains abundant and cheap, medical operators may see some input benefit. They also face the same quality and freshness expectations, and they do not escape the consequences of a national market that still has more biomass than it can use efficiently.

The less visible effect is strategic. Operators that can shift capacity away from commodity flower and toward formats with stronger sell-through, or toward smaller and more targeted cultivation runs, are likely to be in a better position than firms still chasing volume. That does not mean every company must become an extracts company. It means the old assumption that more flower output is a route to durable advantage looks weaker every time the destruction ratio rises.

Canada’s legal market still has buyers, but too much of the wrong flower

The significance of this quarter’s number is not that Canada’s cannabis market is collapsing. The retail data say otherwise. A legal market sustaining monthly sales around C$482 million is substantial by any normal measure.

The significance is that demand at the store level is no longer enough to protect upstream producers from bad production decisions. Early in legalization, it was possible to tell a story in which market expansion would gradually absorb excess cultivation. That story is now much harder to sustain. When stores are still ringing up close to half a billion Canadian dollars a month and producers are still destroying bulk flower at a record share of output, the problem is no longer a temporary launch imbalance. It is a durable mismatch between cultivation plans and market reality.

That reality has consequences. It means some production capacity remains uneconomic even in a growing legal market. It means some inventories that exist on paper are less valuable than they appear. It means scale without market fit remains dangerous. And it means pricing pressure in upstream flower is likely to persist until enough capacity exits, enough operators change mix, or both.

There are still open questions. The first is whether the first-quarter spike reflects a one-time clearing event by multiple operators at once or the start of another sustained upswing in destruction. The second is how much of the excess can be redirected into formats with better demand rather than simply removed from the system. The third is whether stronger retail sales later in 2026, if they arrive, will materially reduce the stock overhang or merely slow the rate at which it worsens.

Health Canada’s published series cannot answer all of that on its own. It does not assign blame firm by firm, and it does not distinguish between product destroyed for quality reasons and product destroyed because it was never likely to sell. But it does provide something more useful than commentary. It provides a clean measure of stress in the legal supply chain.

On that measure, the Canadian market is still in a long sorting process. Consumers are buying. Stores are selling. Yet a record share of bulk dried cannabis is still being destroyed. That is not the profile of a market waiting for demand to arrive. It is the profile of a market still forcing production to shrink, specialize or disappear.